Free Trial

Polen Capital Management LLC Sells 88,018 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

  • Polen Capital Management LLC has reduced its holdings in UnitedHealth Group by 7.8%, selling 88,018 shares during the first quarter, leaving them with over 1 million shares in total.
  • Market analysts have issued target price adjustments for UnitedHealth Group, with Bank of America lowering its estimate from $350 to $300, while UBS Group maintains a "buy" rating.
  • UnitedHealth Group recently announced a quarterly dividend increase to $2.21 per share, resulting in an annualized dividend yield of 3.5%.
  • Looking to Export and Analyze UnitedHealth Group Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Polen Capital Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,037,575 shares of the healthcare conglomerate's stock after selling 88,018 shares during the quarter. UnitedHealth Group comprises 1.7% of Polen Capital Management LLC's investment portfolio, making the stock its 22nd biggest holding. Polen Capital Management LLC owned 0.11% of UnitedHealth Group worth $543,430,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $26,000. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Kapitalo Investimentos Ltda purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $41,000. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $42,000. Finally, IAG Wealth Partners LLC purchased a new position in UnitedHealth Group in the first quarter valued at about $42,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 2.5%

NYSE UNH traded up $6.07 during trading on Friday, hitting $250.74. 10,146,688 shares of the company traded hands, compared to its average volume of 18,423,422. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The business has a fifty day simple moving average of $291.78 and a 200 day simple moving average of $405.18. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $227.46 billion, a P/E ratio of 10.86, a PEG ratio of 1.62 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business posted $6.80 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.5%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Insider Activity at UnitedHealth Group

In other news, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a report on Monday, May 19th. Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Finally, Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $366.52.

Check Out Our Latest Stock Report on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines